Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Tirzepatide (Mounjaro) also affects the glucose-dependent insulinotropic polypeptide (GIP) hormone, which controls metabolism and helps regulate energy balance. The first study into weight-loss ...

When we eat, our intestine produces two hormones called incretins: glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). When scientists discovered, in the 1990s ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

(Zepbound stimulates, rather than blocks, GIP, while both it and MariTide stimulate a second hormone called GLP-1 that’s become central to obesity treatment.) Helicore claims that, by blocking ...

Dubbed the "triple G" drug, retatrutide works by mimicking three hunger-regulating hormones: GLP-1, GIP and glucagon. That appears to have more potent effects on a person's appetite and ...